Patents by Inventor Ulrika Nilsson

Ulrika Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190358301
    Abstract: A histidine-free composition comprising: a high purity factor VIII (r-factor VIII); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor VIII; an amount of calcium chloride for specific stabilization of factor VIII.
    Type: Application
    Filed: December 20, 2018
    Publication date: November 28, 2019
    Applicant: OCTAPHARMA AG
    Inventors: Brita Rippner, Josefin Knutsson, Ulrika Nilsson, Elsa Ivarsson, Irène Agerkvist
  • Publication number: 20190030169
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 31, 2019
    Applicant: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irène Agerkvist
  • Patent number: 10098956
    Abstract: A method for stabilizing a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: October 16, 2018
    Assignee: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irène Agerkvist
  • Patent number: 9943600
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: April 17, 2018
    Assignee: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irene Agerkvist
  • Publication number: 20170189494
    Abstract: A histidine-free composition comprising: a high purity factor VIII (r-factor VIII); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor VIII; an amount of calcium chloride for specific stabilization of factor VIII.
    Type: Application
    Filed: March 20, 2017
    Publication date: July 6, 2017
    Applicant: OCTAPHARMA AG
    Inventors: BRITA RIPPNER, JOSEFIN KNUTSSON, ULRIKA NILSSON, ELSA IVARSSON, ERÈNE AGERKVIST
  • Publication number: 20160256555
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: May 17, 2016
    Publication date: September 8, 2016
    Applicant: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irène Agerkvist
  • Publication number: 20150190478
    Abstract: A histidine-free composition comprising: a high purity factor VIII (r-factor VIII); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor VIII; an amount of calcium chloride for specific stabilization of factor VIII.
    Type: Application
    Filed: December 11, 2014
    Publication date: July 9, 2015
    Inventors: Brita RIPPNER, JOSEFIN ÖSTERBERG, ULRIKA NILSSON, ELSA IVARSSON, IRENE AGERKVIST
  • Publication number: 20140221290
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: April 4, 2014
    Publication date: August 7, 2014
    Applicant: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irene Agerkvist
  • Publication number: 20130161346
    Abstract: A dispenser for perforated web of absorbent paper, tissue, or nonwoven material in the form of a roll or a stack includes a housing forming a compartment, a passage arrangement defining a web passage, and an oblong dispensing opening. Inside the compartment, a web path is defined from a position of the roll or the stack to the oblong dispensing opening including the web passage. An edge portion at each of two lateral short sides of the oblong dispensing opening arranged at a distance from each other narrower than a width of the web separates a sheet from the web along a perforation. The web path changes direction as it passes over a straight edge arranged alongside, and perpendicularly to, the web path. The straight edge, the web passage, and the oblong dispensing opening are arranged directly adjacent to each other in that order seen in a direction of dispensing.
    Type: Application
    Filed: June 30, 2011
    Publication date: June 27, 2013
    Applicant: SCA HYGIENE PRODUCTS AB
    Inventors: Lisa Wolme, Ulrika Nilsson
  • Publication number: 20130116410
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: April 20, 2011
    Publication date: May 9, 2013
    Applicant: OCTAPH ARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irene Agerkvist
  • Publication number: 20110178019
    Abstract: A histidine-free composition comprising: a high purity factor VIII (r-factor VIII); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor VIII; an amount of calcium chloride for specific stabilization of factor VIII.
    Type: Application
    Filed: September 3, 2009
    Publication date: July 21, 2011
    Inventors: Brita Rippner, Josefin Österberg, Ulrika Nilsson, Elsa Ivarsson, Irene Agerkvist
  • Patent number: D655956
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: March 20, 2012
    Assignee: SCA Hygiene Products AB
    Inventors: Lisa Wolme, Ulrika Nilsson